MERSANA THERAPEUTICS INC's ticker is MRSN and the CUSIP is 59045L106. A total of 122 filers reported holding MERSANA THERAPEUTICS INC in Q2 2024. The put-call ratio across all filers is 0.63 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $130,270 | -69.1% | 102,575 | 0.0% | 0.00% | – |
| Q2 2023 | $421,583 | 0.0% | 102,575 | 0.0% | 0.00% | – |
| Q1 2023 | $421,583 | -29.9% | 102,575 | 0.0% | 0.00% | – |
| Q4 2022 | $601,090 | -99.9% | 102,575 | +16.1% | 0.00% | – |
| Q3 2022 | $597,409,000 | +46.3% | 88,374 | 0.0% | 0.00% | – |
| Q2 2022 | $408,288,000 | +15.8% | 88,374 | 0.0% | 0.00% | – |
| Q1 2022 | $352,611,000 | +30.6% | 88,374 | +103.5% | 0.00% | – |
| Q4 2021 | $270,066,000 | -34.0% | 43,419 | 0.0% | 0.00% | – |
| Q3 2021 | $409,441,000 | -30.6% | 43,419 | 0.0% | 0.00% | – |
| Q2 2021 | $589,630,000 | -7.9% | 43,419 | +9.7% | 0.00% | – |
| Q1 2021 | $640,194,000 | -64.7% | 39,567 | -42.0% | 0.00% | -100.0% |
| Q4 2020 | $1,814,323,000 | +54.8% | 68,182 | +8.3% | 0.00% | 0.0% |
| Q3 2020 | $1,171,981,000 | -3.9% | 62,942 | +20.8% | 0.00% | 0.0% |
| Q2 2020 | $1,219,702,000 | – | 52,124 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RHO CAPITAL PARTNERS INC | 818,033 | $14,144,000 | 22.27% |
| ProQuest Associates IV LLC | 955,709 | $16,524,000 | 16.55% |
| NEA Management Company, LLC | 8,144,267 | $140,814,000 | 4.93% |
| Rock Springs Capital Management LP | 1,330,000 | $22,996,000 | 1.06% |
| Cormorant Asset Management, LP | 295,549 | $5,110,000 | 0.90% |
| ArrowMark Colorado Holdings LLC | 477,711 | $8,260,000 | 0.09% |
| Spark Investment Management LLC | 18,688 | $323,000 | 0.02% |
| WELLINGTON MANAGEMENT GROUP LLP | 2,391,404 | $41,348,000 | 0.01% |
| TUDOR INVESTMENT CORP ET AL | 20,000 | $346,000 | 0.01% |
| Laurion Capital Management LP | 50,000 | $865,000 | 0.00% |